491 related articles for article (PubMed ID: 9374671)
1. Inhibition of glycogenolysis enhances gluconeogenic precursor uptake by the liver of conscious dogs.
Shiota M; Jackson PA; Bischoff H; McCaleb M; Scott M; Monohan M; Neal DW; Cherrington AD
Am J Physiol; 1997 Nov; 273(5):E868-79. PubMed ID: 9374671
[TBL] [Abstract][Full Text] [Related]
2. Effects of an acute increase in epinephrine and cortisol on carbohydrate metabolism during insulin deficiency.
Goldstein RE; Abumrad NN; Lacy DB; Wasserman DH; Cherrington AD
Diabetes; 1995 Jun; 44(6):672-81. PubMed ID: 7789632
[TBL] [Abstract][Full Text] [Related]
3. Impact of a glycogen phosphorylase inhibitor and metformin on basal and glucagon-stimulated hepatic glucose flux in conscious dogs.
Torres TP; Sasaki N; Donahue EP; Lacy B; Printz RL; Cherrington AD; Treadway JL; Shiota M
J Pharmacol Exp Ther; 2011 Jun; 337(3):610-20. PubMed ID: 21363927
[TBL] [Abstract][Full Text] [Related]
4. Effect of epinephrine on glycogenolysis and gluconeogenesis in conscious overnight-fasted dogs.
Cherrington AD; Fuchs H; Stevenson RW; Williams PE; Alberti KG; Steiner KE
Am J Physiol; 1984 Aug; 247(2 Pt 1):E137-44. PubMed ID: 6380303
[TBL] [Abstract][Full Text] [Related]
5. Alterations in hepatic gluconeogenic amino acid uptake and gluconeogenesis in the endotoxin treated conscious dog.
Meinz H; Lacy DB; Ejiofor J; McGuinness OP
Shock; 1998 Apr; 9(4):296-303. PubMed ID: 9565259
[TBL] [Abstract][Full Text] [Related]
6. Similar dose responsiveness of hepatic glycogenolysis and gluconeogenesis to glucagon in vivo.
Stevenson RW; Steiner KE; Davis MA; Hendrick GK; Williams PE; Lacy WW; Brown L; Donahue P; Lacy DB; Cherrington AD
Diabetes; 1987 Mar; 36(3):382-9. PubMed ID: 2879758
[TBL] [Abstract][Full Text] [Related]
7. Effect of hyperglucagonemia on hepatic glycogenolysis and gluconeogenesis after a prolonged fast.
Hendrick GK; Frizzell RT; Williams PE; Cherrington AD
Am J Physiol; 1990 May; 258(5 Pt 1):E841-9. PubMed ID: 2185665
[TBL] [Abstract][Full Text] [Related]
8. Small amounts of fructose markedly augment net hepatic glucose uptake in the conscious dog.
Shiota M; Galassetti P; Monohan M; Neal DW; Cherrington AD
Diabetes; 1998 Jun; 47(6):867-73. PubMed ID: 9604861
[TBL] [Abstract][Full Text] [Related]
9. Effects of hyperglycemia on hepatic gluconeogenic flux during glycogen phosphorylase inhibition in the conscious dog.
Edgerton DS; Cardin S; Neal D; Farmer B; Lautz M; Pan C; Cherrington AD
Am J Physiol Endocrinol Metab; 2004 Apr; 286(4):E510-22. PubMed ID: 14644767
[TBL] [Abstract][Full Text] [Related]
10. Control of hepatic glucose output by glucagon and insulin in the intact dog.
Cherrington AD; Chiasson JL; Liljenquist JE; Lacy WW; Park CR
Biochem Soc Symp; 1978; (43):31-45. PubMed ID: 373768
[TBL] [Abstract][Full Text] [Related]
11. A comparison of the effects of selective increases in peripheral or portal insulin on hepatic glucose production in the conscious dog.
Sindelar DK; Balcom JH; Chu CA; Neal DW; Cherrington AD
Diabetes; 1996 Nov; 45(11):1594-604. PubMed ID: 8866566
[TBL] [Abstract][Full Text] [Related]
12. The effect of acute glucagon removal on the metabolic response to stress hormone infusion in the conscious dog.
McGuinness OP; Murrell S; Moran C; Bracy D; Cherrington AD
Metabolism; 1994 Oct; 43(10):1310-7. PubMed ID: 7934986
[TBL] [Abstract][Full Text] [Related]
13. Portal adrenergic blockade does not inhibit the gluconeogenic effects of circulating catecholamines on the liver.
Chu CA; Sindelar DK; Neal DW; Cherrington AD
Metabolism; 1997 Apr; 46(4):458-65. PubMed ID: 9109855
[TBL] [Abstract][Full Text] [Related]
14. Dose-related effects of epinephrine on glucose production in conscious dogs.
Stevenson RW; Steiner KE; Connolly CC; Fuchs H; Alberti KG; Williams PE; Cherrington AD
Am J Physiol; 1991 Mar; 260(3 Pt 1):E363-70. PubMed ID: 2003590
[TBL] [Abstract][Full Text] [Related]
15. Glucagon is a primary controller of hepatic glycogenolysis and gluconeogenesis during muscular work.
Wasserman DH; Spalding JA; Lacy DB; Colburn CA; Goldstein RE; Cherrington AD
Am J Physiol; 1989 Jul; 257(1 Pt 1):E108-17. PubMed ID: 2665514
[TBL] [Abstract][Full Text] [Related]
16. Role of gluconeogenesis in sustaining glucose production during hypoglycemia caused by continuous insulin infusion in conscious dogs.
Frizzell RT; Hendrick GK; Biggers DW; Lacy DB; Donahue DP; Green DR; Carr RK; Williams PE; Stevenson RW; Cherrington AD
Diabetes; 1988 Jun; 37(6):749-59. PubMed ID: 3289995
[TBL] [Abstract][Full Text] [Related]
17. Insulin sensitively controls the glucagon response to mild hypoglycemia in the dog.
Igawa K; Mugavero M; Shiota M; Neal DW; Cherrington AD
Diabetes; 2002 Oct; 51(10):3033-42. PubMed ID: 12351444
[TBL] [Abstract][Full Text] [Related]
18. Small increases in insulin inhibit hepatic glucose production solely caused by an effect on glycogen metabolism.
Edgerton DS; Cardin S; Emshwiller M; Neal D; Chandramouli V; Schumann WC; Landau BR; Rossetti L; Cherrington AD
Diabetes; 2001 Aug; 50(8):1872-82. PubMed ID: 11473051
[TBL] [Abstract][Full Text] [Related]
19. Hepatic glucose disposition during concomitant portal glucose and amino acid infusions in the dog.
Moore MC; Flakoll PJ; Hsieh PS; Pagliassotti MJ; Neal DW; Monohan MT; Venable C; Cherrington AD
Am J Physiol; 1998 May; 274(5):E893-902. PubMed ID: 9612248
[TBL] [Abstract][Full Text] [Related]
20. Molecular characterization of insulin-mediated suppression of hepatic glucose production in vivo.
Ramnanan CJ; Edgerton DS; Rivera N; Irimia-Dominguez J; Farmer B; Neal DW; Lautz M; Donahue EP; Meyer CM; Roach PJ; Cherrington AD
Diabetes; 2010 Jun; 59(6):1302-11. PubMed ID: 20185816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
